Of these patients, we included 233,730 subjects aged ≥ 18 years, without liver diseases who had ALT levels ≤ 40 IU/l, taken between 30 and 365 days prior to testing positive for the SARS-CoV-2 PCR test. This evidence concerns the gene GPT and liver disorder.